Medicilon has been providing LC-MS/MS-based bioanalysis to a diversified global client base since 2004. The combination of experienced staff and the state-of-the-art instrumentation enables us to deliver high quality data in a timely and cost-effective manner.
We offer tiered services to fit the needs in different drug discovery and development stages, such as high-throughput early DMPK screening, GLP-compliant full/partial method validation and sample analysis for IND-enabling TK, and GCLP-compliant clinical bioanalysis. All our regulated bioanalytical services are also well aligned with the latest FDA/EMA/MHLW/CNDA bioanalytical guidelines.
